213 related articles for article (PubMed ID: 25054291)
1. Biomarkers usher in era of personalized care for malignant glioma patients.
Chakravarti A; Palanichamy K; Bell EH
CNS Oncol; 2012 Sep; 1(1):3-6. PubMed ID: 25054291
[No Abstract] [Full Text] [Related]
2. Molecular and genetic pathways in gliomas: the future of personalized therapeutics.
Grant R; Kolb L; Moliterno J
CNS Oncol; 2014 Mar; 3(2):123-36. PubMed ID: 25055018
[TBL] [Abstract][Full Text] [Related]
3. Neuro-oncology: Implications of the molecular era.
Ruff MW; Uhm JH; Benarroch EE
Neurology; 2019 Mar; 92(12):568-574. PubMed ID: 30760635
[TBL] [Abstract][Full Text] [Related]
4. [Personalized therapy for gliomas].
Wick W; Hau P
Nervenarzt; 2015 Jun; 86(6):692, 694-6, 698-700. PubMed ID: 26022855
[TBL] [Abstract][Full Text] [Related]
5. Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.
Wen PY; Reardon DA
Nat Rev Neurol; 2016 Feb; 12(2):69-70. PubMed ID: 26782337
[No Abstract] [Full Text] [Related]
6. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
[TBL] [Abstract][Full Text] [Related]
7. [Biomarkers of glioma: recent advance and potential applications].
Yu SZ; Wang Q
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):145-7. PubMed ID: 19575846
[No Abstract] [Full Text] [Related]
8. From standard treatment to personalized medicine: role of IDH1 mutations in low-grade glioma evolution and treatment.
Ferroli P; Acerbi F; Finocchiaro G
World Neurosurg; 2010 Apr; 73(4):234-6. PubMed ID: 20849763
[No Abstract] [Full Text] [Related]
9. Prioritizing uncharacterized genes in the search for glioma biomarkers.
Towner RA; Wren JD
CNS Oncol; 2014 Mar; 3(2):93-5. PubMed ID: 25055012
[No Abstract] [Full Text] [Related]
10. Incorporation of prognostic and predictive factors into glioma clinical trials.
Johnson DR; Galanis E
Curr Oncol Rep; 2013 Feb; 15(1):56-63. PubMed ID: 23125011
[TBL] [Abstract][Full Text] [Related]
11. Correlative studies in neuro-oncology trials: should they influence treatment?
Hegi ME; Stupp R
Curr Oncol Rep; 2006 Jan; 8(1):54-7. PubMed ID: 16464404
[TBL] [Abstract][Full Text] [Related]
12. Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science.
Hochberg FH; Atai NA; Gonda D; Hughes MS; Mawejje B; Balaj L; Carter RS
Expert Rev Mol Diagn; 2014 May; 14(4):439-52. PubMed ID: 24746164
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive metabolic imaging of brain tumours in the era of precision medicine.
Kim MM; Parolia A; Dunphy MP; Venneti S
Nat Rev Clin Oncol; 2016 Dec; 13(12):725-739. PubMed ID: 27430748
[TBL] [Abstract][Full Text] [Related]
14. Circulating biomarkers for high-grade glioma.
Loo HK; Mathen P; Lee J; Camphausen K
Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
[No Abstract] [Full Text] [Related]
15. Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnostics.
Hench J; Bihl M; Bratic Hench I; Hoffmann P; Tolnay M; Bösch Al Jadooa N; Mariani L; Capper D; Frank S
Neuro Oncol; 2018 Nov; 20(12):1682-1683. PubMed ID: 30169880
[No Abstract] [Full Text] [Related]
16. Molecular profiling of gliomas--time for a regional service.
Hannan C; Al-Rashid S; Herron B; Conkey D; Harney J; Lyness J; Moss J; Flannery T
Ulster Med J; 2014 May; 83(2):120-1. PubMed ID: 25075145
[No Abstract] [Full Text] [Related]
17. High grade glioma--the arrival of the molecular diagnostic era for patients over the age of 65 years in the UK.
Jefferies SJ; Harris FP; Price SJ; Collins VP; Watts C
Clin Oncol (R Coll Radiol); 2013 Jul; 25(7):391-3. PubMed ID: 23615180
[No Abstract] [Full Text] [Related]
18. Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.
Andronesi OC; Loebel F; Bogner W; Marjańska M; Vander Heiden MG; Iafrate AJ; Dietrich J; Batchelor TT; Gerstner ER; Kaelin WG; Chi AS; Rosen BR; Cahill DP
Clin Cancer Res; 2016 Apr; 22(7):1632-41. PubMed ID: 26534967
[TBL] [Abstract][Full Text] [Related]
19. [Molecular Classification and Personalized Treatment of Gliomas].
Sasaki H; Yoshida K
No Shinkei Geka; 2016 Mar; 44(3):185-201. PubMed ID: 26965060
[No Abstract] [Full Text] [Related]
20. MicroRNAs might be promising biomarkers of human gliomas.
Wang H; Yuan X; Zhou Z; Hu J; Zhang T; Hu S; Luo J; Li X
Asian Pac J Cancer Prev; 2011; 12(4):833-5. PubMed ID: 21790212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
